PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Study finds lower mortality rate for men at high risk for death from prostate cancer who received early postoperative radiation therapy

In a large, international retrospective study, men at high risk for death from prostate cancer had a significant reduction in all-cause mortality if treated with radiation shortly after surgery

2021-06-04
(Press-News.org) In a large, international retrospective study, men at high risk for death from prostate cancer had a significant reduction in all-cause mortality if treated with radiation shortly after surgery.

Prostate cancer is one of the most common forms of cancer among men, and about 1-in-8 of them will be diagnosed with it during their lifetime. While most men are cured with available treatment, there remains a group at high risk for death. In the United States in 2020, 33,330 men died from the disease, making prostate cancer the second leading cause of cancer death for men in this country. Therefore, among those at highest risk of recurrence, metastasis, and death from prostate cancer, understanding what steps can be taken to lower these risks could save and extend lives.

Early results from three randomized, clinical trials reported no benefit to giving adjuvant radiation therapy (i.e. when the prostate-specific antigen (PSA) level is not measurable) rather than early salvage radiation therapy (i.e. when the PSA level becomes measurable, signaling recurrence). But these three studies had very small numbers of men at high risk for death from prostate cancer. A new, retrospective study focuses on men who have both high-grade prostate cancer that extends outside the prostate and/or has spread into the lymph nodes. For these men who are at high risk of dying from the disease, there was a significant reduction in the risk of death with adjuvant radiation therapy (aRT) use, suggesting that it should be offered to these men. Results are published in The Journal of Clinical Oncology.

"We found that men at highest risk for dying from prostate cancer may lose the chance for cure if we wait for the PSA to become measurable before delivering radiation after surgery," said corresponding and senior author Anthony D'Amico, MD, PhD, professor and chief of Genitourinary Radiation Oncology at Brigham and Women's Hospital and Dana-Farber Cancer Institute. "While three previous randomized studies have largely encompassed men at very low risk of dying from prostate cancer after surgery, men at high risk of dying from prostate cancer have the most to lose from delaying the use of early and potentially life-saving radiation therapy. We focused on these patients and on the sentinel endpoint of mortality." To conduct their study, D'Amico and colleagues leveraged a cohort of more than 26,000 men treated between 1989 and 2016 across the U.S. and Germany. The cohort included 2,424 patients who were at high risk for dying from prostate cancer despite surgery -- men with a Gleason score of 8-10 and extension of the cancer beyond the prostate capsule and/or into pelvic lymph nodes.

The researchers found that adjuvant radiation therapy was associated with significantly lower all-cause mortality. Among men with high-grade prostate cancer that extended outside the prostate, the risk of death was reduced by two-thirds. Ten years after radical prostatectomy, the rate of all-cause mortality was 5 percent among those who received adjuvant radiation therapy, compared to 22 percent among those who had received sRT. Among those whose cancer had spread to the lymph nodes, a group many consider incurable, the risk of death was reduced by one-third.

The authors note that their study is retrospective in nature, and while they took many steps to adjust and control for relevant patient- and cancer-related factors, some degree of selection bias may exist. For example, men selected for adjuvant as compared with early sRT might have been healthier. Therefore, it is possible that the risk reduction in death could overestimate the true risk reduction. "For those men at high risk of dying from prostate cancer despite surgery, adjuvant radiation therapy rather than waiting until the PSA is measurable appears to be able to reduce all-cause mortality," said D'Amico. "If we want to make a global impact in driving down the number of people who die from prostate cancer, it's important to examine what can be done to help these men who are most at risk for dying from this disease."

INFORMATION:

Paper cited: Tilki, D et al. "Adjuvant Versus Early Salvage Radiation Therapy for Men at High Risk for Recurrence Following Radical Prostatectomy for Prostate Cancer and the Risk of Death" JCO DOI: 10.1200/JCO.20.03714



ELSE PRESS RELEASES FROM THIS DATE:

SLAS Discovery's June issue on synthetic biology available now

2021-06-04
Oak Brook, IL - The June edition of SLAS Discovery features the cover article, "A Perspective on Synthetic Biology in Drug Discovery and Development--Current Impact and Future Opportunities" by Florian David, Ph.D. (Chalmers University of Technology, Gothenburg, Sweden), Andrew M. Davis, Ph.D. (AstraZeneca, Cambridge, England, UK). Michael Gossing, Ph.D., Martin A. Hayes, Ph.D., and Elvira Romero, Ph.D., and Louis H. Scott, Ph.D. (AstraZeneca, Gothenburg, Sweden), and Mark J. Wigglesworth, Ph.D. (AstraZeneca, London, England, UK). In January 2021, a survey of immunologists, infectious-disease researchers and virologists found that 90% of respondents believe SARS-CoV-2 will become endemic, continuing to circulate in pockets of the global population ...

Nutritional supplement proves 92% effective in boosting brain function

2021-06-04
An international subject pool was studied to confirm the effectiveness of a whole food complete vitamin and meal replacement product, IQed. The article, co-authored by Lisa Geng; Francine Hamel, EdD, SLP-CCC; Doreen Lewis, Ph.D., appeared in the peer-reviewed journal, Alternative Therapies (Altern Ther Health Med 2021 Mar;27(2):11-20(. The findings indicate that the carefully developed nutritional supplement, IQed Smart Nutrition, can help bolster key functions for people with a wide range of prevalent diagnoses including Autism, Apraxia, ...

SLAS Technology June special issue on 3D cell culture

2021-06-04
Oak Brook, IL - The June edition of SLAS Technology is a Special Issue entitled, "Emerging Trends in 3D Cell Culture: High-Throughput Screening, Disease Modeling and Translational Medicine." Free online access to the articles in this collection is courtesy of Corning Life Sciences, the issue's sponsor. Precision medicine is becoming an increasingly popular and powerful way to target and treat human diseases. Patient-derived cellular models ushered in high-throughput screenings (HTS) in laboratory automation. While the upkeep and expansion of cells for HTS is predominantly manual, this special issue explores an automated avenue for HTS in research settings that considers the expansion of cells. This design is flexible for research and development ...

Computer simulations of the brain can predict language recovery in stroke survivors

2021-06-04
At Boston University, a team of researchers is working to better understand how language and speech is processed in the brain, and how to best rehabilitate people who have lost their ability to communicate due to brain damage caused by a stroke, trauma, or another type of brain injury. This type of language loss is called aphasia, a long-term neurological disorder caused by damage to the part of the brain responsible for language production and processing that impacts over a million people in the US. "It's a huge problem," says Swathi Kiran, director of BU's Aphasia Research Lab, and College of Health & Rehabilitation Sciences: Sargent College associate dean for research and ...

Newly approved drug effective against lung cancer caused by genetic mutation

2021-06-04
The new drug sotorasib reduces tumor size and shows promise in improving survival among patients with lung tumors caused by a specific DNA mutation, according to results of a global phase 2 clinical trial. The drug is designed to shut down the effects of the mutation, which is found in about 13% of patients with lung adenocarcinoma, a common type of non-small-cell lung cancer. The Food and Drug Administration approved sotorasib May 28 as a targeted therapy for patients with non-small-cell lung cancer whose tumors express a specific mutation -- called ...

Study of past South Asian monsoons suggests stronger monsoon rainfall in the future

Study of past South Asian monsoons suggests stronger monsoon rainfall in the future
2021-06-04
PROVIDENCE, R.I. [Brown University] -- A new study of monsoon rainfall on the Indian subcontinent over the past million years provides vital clues about how the monsoons will respond to future climate change. The study, published in Science Advances, found that periodic changes in the intensity of monsoon rainfall over the past 900,000 years were associated with fluctuations in atmospheric carbon dioxide (CO2), continental ice volume and moisture import from the southern hemisphere Indian Ocean. The findings bolster climate model predictions that rising CO2 and higher global temperatures will lead to stronger monsoon seasons. "We show that over the last 900,000 years, higher CO2 levels along with associated changes in ice volume and moisture ...

Soft tissue measurements critical to hominid reconstruction

Soft tissue measurements critical to hominid reconstruction
2021-06-04
Accurate soft tissue measurements are critical when making reconstructions of human ancestors, a new study from the University of Adelaide and Arizona State University has found. "Reconstructing extinct members of the Hominidae, or hominids, including their facial soft tissue, has become increasingly popular with many approximations of their faces presented in museum exhibitions, popular science publications and at conference presentations worldwide," said lead author PhD student Ryan M. Campbell from the University of Adelaide. "It is essential that accurate facial soft tissue thickness measurements are used when reconstructing the faces of hominids to reduce the variability exhibited in reconstructions of the same individuals." Hominids have been readily accepted ...

Substantial carbon dioxide emissions from northern peatlands drained for crop cultivation

Substantial carbon dioxide emissions from northern peatlands drained for crop cultivation
2021-06-04
A new study shows that substantial amounts of carbon dioxide were released during the last millennium because of crop cultivation on peatlands in the Northern Hemisphere. Only about half of the carbon released through the conversion of peat to croplands was compensated by continuous carbon absorption in natural northern peatlands. Peatlands are a type of wetland which store more organic carbon than any other type of land ecosystem in the world. Due to waterlogged conditions, dead plant materials do not fully decay and carbon accumulates in peatlands over thousands of years. Therefore, natural peatlands help to cool the climate by capturing carbon dioxide (CO2) from the atmosphere ...

Newly approved targeted therapy sotorasib prolongs survival in KRAS G12C-mutated lung cancer

2021-06-04
ABSTRACT #9003 HOUSTON - Results from the Phase II cohort of the CodeBreaK 100 study showed that treatment with the KRAS G12C inhibitor sotorasib achieved a 37.1% objective response rate and 12.5 months median overall survival in previously treated patients with KRAS G12C-mutated non-small cell lung cancer (NSCLC), according to researchers from The University of Texas MD Anderson Cancer Center. The findings were presented today at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting and published in the New England Journal of Medicine. Trial results indicated the targeted therapy was safe and tolerable in a heavily pre-treated patient population. The reported findings make sotorasib the first KRAS G12C inhibitor to demonstrate overall survival benefit in a registrational ...

"Mexican variant" and monitoring actions of SARS-CoV-2 genome

2021-06-04
A research group of the Department of Pharmacy and Biotechnology of the University of Bologna analyzed more than one million SARS-CoV-2 genome sequences. This analysis led to the identification of a new variant that, over the past weeks, has been spreading mostly in Mexico but has also been found in Europe. Their paper published in the Journal of Medical Virology presented the so-called "Mexican variant", whose scientific name is T478K. Like other strains, this presents a mutation in the Spike protein, which allows coronaviruses to attach to and penetrate their targeted cells. "This variant has been increasingly spreading among people in North America, particularly in Mexico. To date, this variant covers more than 50% of the existing viruses in this area. The ...

LAST 30 PRESS RELEASES:

Thirty-year mystery of dissonance in the “ringing” of black holes explained

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate

Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative

Structure dictates effectiveness, safety in nanomedicine

[Press-News.org] Study finds lower mortality rate for men at high risk for death from prostate cancer who received early postoperative radiation therapy
In a large, international retrospective study, men at high risk for death from prostate cancer had a significant reduction in all-cause mortality if treated with radiation shortly after surgery